| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Antigen, T-Cell, gamma-delta | 24 | 2025 | 111 | 5.330 |
Why?
|
| T-Lymphocytes | 31 | 2025 | 1275 | 3.850 |
Why?
|
| Lymphocyte Activation | 24 | 2025 | 797 | 2.810 |
Why?
|
| Histocompatibility Antigens Class I | 22 | 2024 | 207 | 2.790 |
Why?
|
| Antigen Presentation | 17 | 2024 | 229 | 2.620 |
Why?
|
| Butyrophilins | 12 | 2025 | 28 | 2.320 |
Why?
|
| Antigens, CD | 12 | 2025 | 476 | 2.210 |
Why?
|
| Antigens, CD1 | 7 | 2016 | 37 | 1.940 |
Why?
|
| T-Lymphocyte Subsets | 8 | 2020 | 287 | 1.710 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 10 | 2024 | 113 | 1.430 |
Why?
|
| Antigens, CD1d | 8 | 2015 | 32 | 1.280 |
Why?
|
| Antibodies, Monoclonal | 6 | 2025 | 1395 | 1.240 |
Why?
|
| Receptors, Antigen, T-Cell | 14 | 2024 | 424 | 1.230 |
Why?
|
| Protein Binding | 25 | 2025 | 1534 | 1.170 |
Why?
|
| Glycoproteins | 6 | 2016 | 220 | 1.130 |
Why?
|
| Lipids | 4 | 2018 | 278 | 1.110 |
Why?
|
| Minor Histocompatibility Antigens | 8 | 2024 | 40 | 1.070 |
Why?
|
| Complementarity Determining Regions | 3 | 2020 | 25 | 1.030 |
Why?
|
| Mucosal-Associated Invariant T Cells | 6 | 2024 | 13 | 0.980 |
Why?
|
| Models, Molecular | 10 | 2018 | 1353 | 0.950 |
Why?
|
| Genes, MHC Class I | 10 | 2014 | 46 | 0.900 |
Why?
|
| Ligands | 16 | 2024 | 476 | 0.900 |
Why?
|
| Killer Cells, Natural | 7 | 2017 | 286 | 0.850 |
Why?
|
| Phosphatidylserines | 5 | 2023 | 21 | 0.840 |
Why?
|
| Evolution, Molecular | 8 | 2015 | 878 | 0.790 |
Why?
|
| Animals | 56 | 2025 | 28155 | 0.780 |
Why?
|
| Antigens | 14 | 2024 | 224 | 0.780 |
Why?
|
| Pan troglodytes | 10 | 2015 | 203 | 0.760 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2023 | 86 | 0.760 |
Why?
|
| Protein Conformation | 13 | 2017 | 914 | 0.730 |
Why?
|
| Recombinant Proteins | 6 | 2020 | 988 | 0.710 |
Why?
|
| Major Histocompatibility Complex | 4 | 2019 | 86 | 0.700 |
Why?
|
| Superantigens | 1 | 2021 | 24 | 0.700 |
Why?
|
| Clostridiales | 1 | 2021 | 18 | 0.700 |
Why?
|
| Autoantigens | 4 | 2025 | 138 | 0.690 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2021 | 107 | 0.690 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2021 | 87 | 0.690 |
Why?
|
| Antigens, Bacterial | 4 | 2014 | 135 | 0.680 |
Why?
|
| Protein Multimerization | 3 | 2020 | 191 | 0.680 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2021 | 103 | 0.660 |
Why?
|
| Antibody Affinity | 1 | 2020 | 38 | 0.660 |
Why?
|
| Antibody Specificity | 1 | 2020 | 126 | 0.650 |
Why?
|
| Inclusion Bodies | 1 | 2020 | 31 | 0.620 |
Why?
|
| Sulfoglycosphingolipids | 3 | 2013 | 6 | 0.580 |
Why?
|
| Mice | 23 | 2025 | 12269 | 0.550 |
Why?
|
| B-Lymphocytes | 5 | 2021 | 701 | 0.540 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 240 | 0.530 |
Why?
|
| Signal Transduction | 4 | 2025 | 3502 | 0.530 |
Why?
|
| Protein Structure, Tertiary | 8 | 2015 | 729 | 0.520 |
Why?
|
| Humans | 73 | 2025 | 93515 | 0.510 |
Why?
|
| Crystallography, X-Ray | 12 | 2018 | 520 | 0.510 |
Why?
|
| Primates | 3 | 2011 | 157 | 0.500 |
Why?
|
| Software | 1 | 2020 | 670 | 0.490 |
Why?
|
| Peptides | 6 | 2021 | 656 | 0.450 |
Why?
|
| HLA Antigens | 5 | 2019 | 228 | 0.440 |
Why?
|
| Mycobacterium | 1 | 2014 | 19 | 0.430 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2025 | 337 | 0.420 |
Why?
|
| Cell Line | 16 | 2023 | 2464 | 0.420 |
Why?
|
| Mycobacterium tuberculosis | 5 | 2016 | 208 | 0.420 |
Why?
|
| Organophosphorus Compounds | 3 | 2020 | 46 | 0.410 |
Why?
|
| Lipid Mobilization | 1 | 2013 | 2 | 0.410 |
Why?
|
| Binding Sites | 10 | 2021 | 1133 | 0.400 |
Why?
|
| Amino Acid Sequence | 16 | 2021 | 2012 | 0.400 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 183 | 0.390 |
Why?
|
| Membrane Proteins | 3 | 2021 | 1264 | 0.390 |
Why?
|
| Natural Killer T-Cells | 6 | 2013 | 46 | 0.390 |
Why?
|
| Molecular Sequence Data | 18 | 2014 | 2910 | 0.380 |
Why?
|
| Polymorphism, Genetic | 7 | 2014 | 826 | 0.370 |
Why?
|
| Receptors, Immunologic | 4 | 2017 | 140 | 0.360 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2011 | 9 | 0.350 |
Why?
|
| Lectins, C-Type | 3 | 2017 | 89 | 0.330 |
Why?
|
| HLA-C Antigens | 6 | 2010 | 17 | 0.330 |
Why?
|
| Antibodies | 1 | 2012 | 348 | 0.330 |
Why?
|
| Epitopes | 4 | 2023 | 254 | 0.320 |
Why?
|
| Hepatitis A Virus Cellular Receptor 1 | 4 | 2021 | 16 | 0.320 |
Why?
|
| Antigens, Ly | 2 | 2007 | 36 | 0.310 |
Why?
|
| Protein Structure, Secondary | 5 | 2021 | 337 | 0.300 |
Why?
|
| Immunity, Innate | 1 | 2013 | 463 | 0.290 |
Why?
|
| Hemiterpenes | 2 | 2020 | 6 | 0.290 |
Why?
|
| Autoimmunity | 3 | 2025 | 189 | 0.280 |
Why?
|
| Structure-Activity Relationship | 4 | 2017 | 422 | 0.270 |
Why?
|
| Genetic Variation | 6 | 2011 | 1415 | 0.270 |
Why?
|
| Muromegalovirus | 1 | 2007 | 2 | 0.260 |
Why?
|
| Conserved Sequence | 4 | 2012 | 209 | 0.260 |
Why?
|
| Base Sequence | 11 | 2014 | 2220 | 0.260 |
Why?
|
| CD3 Complex | 2 | 2019 | 135 | 0.250 |
Why?
|
| Diphosphates | 2 | 2018 | 15 | 0.250 |
Why?
|
| Histocompatibility Antigens | 3 | 2019 | 37 | 0.230 |
Why?
|
| Phosphorylation | 5 | 2024 | 1133 | 0.230 |
Why?
|
| CRISPR-Cas Systems | 2 | 2023 | 98 | 0.230 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2017 | 96 | 0.220 |
Why?
|
| Cross Reactions | 2 | 2020 | 113 | 0.220 |
Why?
|
| Protein Isoforms | 4 | 2014 | 295 | 0.220 |
Why?
|
| Immune Tolerance | 2 | 2025 | 375 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 6 | 2025 | 3435 | 0.210 |
Why?
|
| Ribitol | 1 | 2024 | 1 | 0.210 |
Why?
|
| Computational Biology | 3 | 2020 | 578 | 0.210 |
Why?
|
| alpha-Synuclein | 1 | 2024 | 24 | 0.210 |
Why?
|
| Uracil | 1 | 2024 | 54 | 0.210 |
Why?
|
| Pongo pygmaeus | 2 | 2002 | 11 | 0.200 |
Why?
|
| Galactosylceramides | 2 | 2013 | 6 | 0.190 |
Why?
|
| Gene Editing | 1 | 2023 | 51 | 0.190 |
Why?
|
| Proteins | 2 | 2005 | 803 | 0.190 |
Why?
|
| Protein Structure, Quaternary | 3 | 2013 | 100 | 0.190 |
Why?
|
| Cell Membrane | 3 | 2023 | 664 | 0.190 |
Why?
|
| Models, Immunological | 2 | 2014 | 84 | 0.180 |
Why?
|
| Escherichia coli | 3 | 2018 | 563 | 0.180 |
Why?
|
| Species Specificity | 6 | 2016 | 684 | 0.180 |
Why?
|
| Thymus Gland | 3 | 2021 | 196 | 0.180 |
Why?
|
| Phylogeny | 8 | 2014 | 1266 | 0.180 |
Why?
|
| Parkinson Disease | 1 | 2024 | 175 | 0.180 |
Why?
|
| Alleles | 9 | 2002 | 1139 | 0.180 |
Why?
|
| Mucins | 1 | 2021 | 40 | 0.170 |
Why?
|
| Clone Cells | 4 | 2017 | 219 | 0.170 |
Why?
|
| Lipid Bilayers | 2 | 2024 | 146 | 0.170 |
Why?
|
| Cattle | 3 | 2017 | 397 | 0.160 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2021 | 84 | 0.160 |
Why?
|
| Carrier Proteins | 1 | 2023 | 663 | 0.160 |
Why?
|
| Histocompatibility Antigens Class II | 4 | 2021 | 171 | 0.160 |
Why?
|
| Protein Refolding | 1 | 2020 | 2 | 0.160 |
Why?
|
| Sequence Homology, Nucleic Acid | 5 | 2014 | 159 | 0.160 |
Why?
|
| Riboflavin | 1 | 2019 | 7 | 0.160 |
Why?
|
| CD4 Antigens | 1 | 2019 | 80 | 0.150 |
Why?
|
| Gorilla gorilla | 2 | 2014 | 46 | 0.150 |
Why?
|
| Immunologic Surveillance | 1 | 2019 | 14 | 0.150 |
Why?
|
| MART-1 Antigen | 1 | 2018 | 21 | 0.150 |
Why?
|
| Receptors, Natural Killer Cell | 2 | 2017 | 20 | 0.140 |
Why?
|
| Mycobacterium smegmatis | 1 | 2018 | 6 | 0.140 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 2 | 2018 | 8 | 0.140 |
Why?
|
| Nanowires | 1 | 2018 | 6 | 0.140 |
Why?
|
| Receptors, Virus | 2 | 2018 | 74 | 0.140 |
Why?
|
| Silicon | 1 | 2018 | 20 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 392 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 3 | 2016 | 894 | 0.140 |
Why?
|
| Membrane Glycoproteins | 3 | 2018 | 444 | 0.130 |
Why?
|
| Metabolome | 1 | 2018 | 62 | 0.130 |
Why?
|
| HEK293 Cells | 5 | 2020 | 696 | 0.130 |
Why?
|
| Gold | 1 | 2018 | 44 | 0.130 |
Why?
|
| Organophosphates | 1 | 2017 | 6 | 0.130 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2017 | 18 | 0.130 |
Why?
|
| Molecular Mimicry | 1 | 2017 | 17 | 0.130 |
Why?
|
| Biotin | 1 | 2017 | 44 | 0.130 |
Why?
|
| Wound Healing | 1 | 2019 | 373 | 0.130 |
Why?
|
| HLA-A Antigens | 4 | 2011 | 39 | 0.130 |
Why?
|
| HLA-B Antigens | 5 | 1997 | 27 | 0.130 |
Why?
|
| DNA Primers | 3 | 2011 | 531 | 0.130 |
Why?
|
| Tuberculosis Vaccines | 1 | 2016 | 19 | 0.120 |
Why?
|
| rhoB GTP-Binding Protein | 1 | 2016 | 3 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2014 | 404 | 0.120 |
Why?
|
| Dendritic Cells | 3 | 2021 | 536 | 0.120 |
Why?
|
| Flow Cytometry | 2 | 2016 | 712 | 0.120 |
Why?
|
| Mutation | 3 | 2024 | 4272 | 0.120 |
Why?
|
| Sequence Alignment | 3 | 2016 | 352 | 0.120 |
Why?
|
| Viral Proteins | 1 | 2017 | 248 | 0.120 |
Why?
|
| Gene Expression | 1 | 2020 | 1301 | 0.120 |
Why?
|
| Jurkat Cells | 2 | 2013 | 84 | 0.120 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2017 | 304 | 0.110 |
Why?
|
| Cells, Cultured | 6 | 2018 | 2850 | 0.110 |
Why?
|
| Amino Acids | 2 | 2014 | 249 | 0.110 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 160 | 0.110 |
Why?
|
| Callithrix | 1 | 2015 | 15 | 0.110 |
Why?
|
| Tuberculosis | 1 | 2016 | 124 | 0.110 |
Why?
|
| Mutagenesis | 2 | 2013 | 192 | 0.110 |
Why?
|
| Protein Footprinting | 1 | 2014 | 3 | 0.110 |
Why?
|
| Macaca fascicularis | 1 | 2014 | 111 | 0.110 |
Why?
|
| Action Potentials | 1 | 2018 | 581 | 0.110 |
Why?
|
| Melanoma | 1 | 2018 | 495 | 0.110 |
Why?
|
| Glycosylation | 1 | 2014 | 137 | 0.110 |
Why?
|
| Transport Vesicles | 1 | 2014 | 9 | 0.110 |
Why?
|
| Microbiota | 1 | 2019 | 425 | 0.100 |
Why?
|
| Receptors, KIR | 3 | 2010 | 10 | 0.100 |
Why?
|
| Scattering, Radiation | 1 | 2014 | 122 | 0.100 |
Why?
|
| Dimerization | 2 | 2005 | 148 | 0.100 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2014 | 215 | 0.100 |
Why?
|
| Fishes | 1 | 2015 | 144 | 0.100 |
Why?
|
| Tryptophan | 1 | 2014 | 105 | 0.100 |
Why?
|
| Amino Acid Motifs | 2 | 2012 | 119 | 0.100 |
Why?
|
| Glycolipids | 1 | 2013 | 26 | 0.100 |
Why?
|
| Insecta | 2 | 2021 | 55 | 0.100 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 106 | 0.100 |
Why?
|
| Protein Folding | 2 | 2013 | 292 | 0.090 |
Why?
|
| HLA-G Antigens | 1 | 2013 | 52 | 0.090 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 19 | 0.090 |
Why?
|
| Cloning, Molecular | 3 | 2011 | 587 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 3 | 2011 | 893 | 0.090 |
Why?
|
| Entropy | 1 | 2012 | 42 | 0.090 |
Why?
|
| Lysophospholipids | 1 | 2012 | 67 | 0.090 |
Why?
|
| Genes, Overlapping | 1 | 2011 | 4 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2012 | 363 | 0.080 |
Why?
|
| Surface Plasmon Resonance | 2 | 2008 | 48 | 0.080 |
Why?
|
| Biological Products | 1 | 2013 | 178 | 0.080 |
Why?
|
| Haplotypes | 4 | 2002 | 647 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 2 | 2025 | 174 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2011 | 391 | 0.080 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2010 | 11 | 0.080 |
Why?
|
| Membranes | 2 | 2021 | 35 | 0.080 |
Why?
|
| Lysophosphatidylcholines | 1 | 2009 | 17 | 0.080 |
Why?
|
| Hydrogen Bonding | 2 | 2007 | 154 | 0.080 |
Why?
|
| Neurons | 1 | 2018 | 1582 | 0.080 |
Why?
|
| DNA, Complementary | 5 | 2001 | 384 | 0.070 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 1985 | 0.070 |
Why?
|
| Protein Domains | 2 | 2021 | 161 | 0.070 |
Why?
|
| Molecular Docking Simulation | 2 | 2022 | 57 | 0.070 |
Why?
|
| RNA, Small Interfering | 3 | 2016 | 555 | 0.070 |
Why?
|
| Circular Dichroism | 1 | 2008 | 117 | 0.070 |
Why?
|
| Neoplasms | 1 | 2023 | 3169 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2019 | 2121 | 0.070 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2010 | 234 | 0.070 |
Why?
|
| Receptors, NK Cell Lectin-Like | 1 | 2007 | 5 | 0.070 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily A | 1 | 2007 | 4 | 0.070 |
Why?
|
| Protein Engineering | 3 | 2016 | 150 | 0.070 |
Why?
|
| Biological Evolution | 2 | 2017 | 1020 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 1101 | 0.060 |
Why?
|
| Cell Line, Transformed | 4 | 2001 | 152 | 0.060 |
Why?
|
| Baculoviridae | 1 | 2007 | 33 | 0.060 |
Why?
|
| Disulfides | 1 | 2007 | 65 | 0.060 |
Why?
|
| Lymphoma, T-Cell | 1 | 2007 | 61 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 2755 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 1775 | 0.060 |
Why?
|
| Peptide Fragments | 3 | 2017 | 470 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 740 | 0.060 |
Why?
|
| Pedigree | 3 | 2002 | 961 | 0.060 |
Why?
|
| Leukocyte Common Antigens | 1 | 2024 | 50 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2025 | 1587 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2017 | 517 | 0.050 |
Why?
|
| Milk Proteins | 1 | 2023 | 24 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2021 | 481 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2023 | 70 | 0.050 |
Why?
|
| Crystallization | 3 | 2010 | 216 | 0.050 |
Why?
|
| Interferon-gamma | 2 | 2017 | 460 | 0.050 |
Why?
|
| Male | 9 | 2025 | 44557 | 0.040 |
Why?
|
| Cebidae | 1 | 2001 | 4 | 0.040 |
Why?
|
| Cercopithecidae | 1 | 2001 | 14 | 0.040 |
Why?
|
| Single Molecule Imaging | 1 | 2021 | 16 | 0.040 |
Why?
|
| Thymocytes | 1 | 2021 | 31 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2001 | 129 | 0.040 |
Why?
|
| Protein Stability | 1 | 2021 | 103 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 2465 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2002 | 613 | 0.040 |
Why?
|
| Camelids, New World | 1 | 2020 | 4 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2001 | 218 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2001 | 219 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2001 | 2026 | 0.040 |
Why?
|
| Codon | 1 | 2000 | 116 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2019 | 28 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2019 | 71 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2019 | 84 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2019 | 83 | 0.040 |
Why?
|
| Multigene Family | 1 | 2000 | 203 | 0.040 |
Why?
|
| Interleukin-23 | 1 | 2019 | 60 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2000 | 469 | 0.040 |
Why?
|
| Oncorhynchus mykiss | 1 | 1998 | 4 | 0.040 |
Why?
|
| Fish Proteins | 1 | 1998 | 20 | 0.040 |
Why?
|
| Interleukin-17 | 1 | 2019 | 109 | 0.040 |
Why?
|
| Chemokines | 1 | 1998 | 76 | 0.040 |
Why?
|
| Hominidae | 1 | 1999 | 106 | 0.030 |
Why?
|
| Electrochemical Techniques | 1 | 2018 | 6 | 0.030 |
Why?
|
| Photochemical Processes | 1 | 2018 | 15 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2001 | 1052 | 0.030 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 2 | 2010 | 13 | 0.030 |
Why?
|
| Hepacivirus | 1 | 1999 | 135 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2018 | 72 | 0.030 |
Why?
|
| Indians, South American | 1 | 1997 | 6 | 0.030 |
Why?
|
| Lepidoptera | 1 | 2017 | 15 | 0.030 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2017 | 4 | 0.030 |
Why?
|
| Leukocyte Immunoglobulin-like Receptor B1 | 1 | 2017 | 2 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2017 | 18 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 2017 | 103 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2017 | 42 | 0.030 |
Why?
|
| Biotinylation | 1 | 2017 | 42 | 0.030 |
Why?
|
| Serum Albumin, Bovine | 1 | 2017 | 47 | 0.030 |
Why?
|
| K562 Cells | 1 | 2017 | 48 | 0.030 |
Why?
|
| Indians, North American | 1 | 1997 | 48 | 0.030 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2017 | 96 | 0.030 |
Why?
|
| Lasers | 1 | 2017 | 101 | 0.030 |
Why?
|
| X-Ray Diffraction | 1 | 2017 | 131 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 83 | 0.030 |
Why?
|
| Female | 7 | 2025 | 48702 | 0.030 |
Why?
|
| Hepatitis C | 1 | 1999 | 182 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 292 | 0.030 |
Why?
|
| Light | 1 | 2018 | 288 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 295 | 0.030 |
Why?
|
| Skin | 1 | 2019 | 578 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 319 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2001 | 970 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2017 | 277 | 0.030 |
Why?
|
| DNA | 2 | 1999 | 1265 | 0.030 |
Why?
|
| HLA-B8 Antigen | 1 | 1995 | 3 | 0.030 |
Why?
|
| Transcriptome | 1 | 2021 | 762 | 0.030 |
Why?
|
| Bacteria | 1 | 2019 | 509 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1518 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 2484 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2016 | 260 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 730 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 172 | 0.030 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2014 | 4 | 0.030 |
Why?
|
| Vaccination | 1 | 2016 | 304 | 0.030 |
Why?
|
| Actin Cytoskeleton | 1 | 2016 | 196 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 38 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2016 | 448 | 0.030 |
Why?
|
| Diphosphonates | 1 | 2014 | 36 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 688 | 0.030 |
Why?
|
| Amino Acid Substitution | 2 | 2005 | 331 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 2013 | 32 | 0.030 |
Why?
|
| Imidazoles | 1 | 2014 | 138 | 0.020 |
Why?
|
| Propionates | 1 | 2013 | 31 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2013 | 102 | 0.020 |
Why?
|
| Fatty Acid Synthases | 1 | 2013 | 9 | 0.020 |
Why?
|
| beta 2-Microglobulin | 1 | 2012 | 23 | 0.020 |
Why?
|
| Antibodies, Immobilized | 1 | 2012 | 1 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2012 | 22 | 0.020 |
Why?
|
| Genome, Human | 1 | 1997 | 823 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 1721 | 0.020 |
Why?
|
| Receptors, KIR2DL4 | 2 | 2002 | 2 | 0.020 |
Why?
|
| Rats | 1 | 2018 | 4072 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 1741 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2010 | 660 | 0.020 |
Why?
|
| HLA-A2 Antigen | 1 | 2011 | 32 | 0.020 |
Why?
|
| Antigenic Variation | 1 | 2010 | 28 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2012 | 176 | 0.020 |
Why?
|
| Pongo | 1 | 2010 | 9 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 438 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1621 | 0.020 |
Why?
|
| X-Rays | 1 | 2010 | 138 | 0.020 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2010 | 17 | 0.020 |
Why?
|
| Signaling Lymphocytic Activation Molecule Associated Protein | 1 | 2010 | 5 | 0.020 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 2010 | 15 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 136 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 2012 | 261 | 0.020 |
Why?
|
| Pregnancy | 1 | 2017 | 3147 | 0.020 |
Why?
|
| Phosphorylcholine | 1 | 2009 | 22 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 273 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 411 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2495 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2010 | 109 | 0.020 |
Why?
|
| Sphingosine | 1 | 2009 | 73 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 641 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 1768 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 2009 | 145 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 179 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 880 | 0.020 |
Why?
|
| Histocompatibility Testing | 2 | 1999 | 140 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 887 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 878 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1931 | 0.010 |
Why?
|
| Cytokines | 1 | 2009 | 863 | 0.010 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2005 | 101 | 0.010 |
Why?
|
| Myelin Basic Protein | 1 | 2005 | 37 | 0.010 |
Why?
|
| Peptide Library | 1 | 2005 | 84 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 1234 | 0.010 |
Why?
|
| Calorimetry | 1 | 2003 | 15 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2003 | 27 | 0.010 |
Why?
|
| Inflammation | 1 | 2009 | 1050 | 0.010 |
Why?
|
| Moths | 1 | 2003 | 32 | 0.010 |
Why?
|
| Insect Proteins | 1 | 2003 | 90 | 0.010 |
Why?
|
| Thermodynamics | 1 | 2003 | 325 | 0.010 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily D | 1 | 2002 | 8 | 0.010 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2002 | 9 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2002 | 28 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 1762 | 0.010 |
Why?
|
| Temperature | 1 | 2003 | 424 | 0.010 |
Why?
|
| Lectins | 1 | 2002 | 83 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 1922 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2002 | 700 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 27918 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 1998 | 22 | 0.010 |
Why?
|
| Chemokines, CC | 1 | 1998 | 36 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1999 | 319 | 0.010 |
Why?
|
| Acute Disease | 1 | 1999 | 841 | 0.010 |
Why?
|
| HLA-B15 Antigen | 1 | 1996 | 2 | 0.010 |
Why?
|
| HLA-A24 Antigen | 1 | 1996 | 21 | 0.010 |
Why?
|
| Thailand | 1 | 1996 | 66 | 0.010 |
Why?
|
| Serology | 1 | 1994 | 3 | 0.010 |
Why?
|
| Liver | 1 | 1999 | 1210 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1996 | 419 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 1028 | 0.010 |
Why?
|
| Cysteine | 1 | 1994 | 145 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1999 | 4560 | 0.010 |
Why?
|